Anti-viral Mechanisms of Defensins
Anti-viral Mechanisms of Defensins
批准号:
10608151
负责人:
ROBERT MCKENNA
金额:
$64.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-04-10 至 2025-04-30
关键词:
AdenovirusesAnimalsAnti-Bacterial AgentsAntiviral AgentsAttentionBindingBinding SitesBiochemicalBiologyCapsidCell Culture TechniquesCellsClinicalComparative StudyComplementConfocal MicroscopyDefensinsDependovirusDevelopmentDirected Molecular EvolutionDiseaseDisparateEnteralEpitopesEvolutionFamilyGenetic studyGoalsHost DefenseHumanHuman PapillomavirusImmuneImmune systemImmunityIn VitroInfectionInnate Immune ResponseInnate Immune SystemIntegration Host FactorsKnowledgeLipid BilayersMapsMediatingModelingMolecularMusMutagenesisMyelogenousOralPapillomavirusParvovirusPathogenesisPathogenicityPeptidesPropertyPublishingResistanceResolutionRoleRotavirusRotavirus InfectionsRouteShapesSiteSmall IntestinesTestingTherapeuticTimeTropismVaccine DesignVaccinesViralViral Drug ResistanceViral PathogenesisViral PhysiologyViral VectorVirusVirus DiseasesWorkalpha-Defensinsantimicrobial peptidearms raceclinically relevantdesignenteric adenovirus infectionexperimental studygastrointestinal epitheliumgenetic approachhuman pathogenin vivoinnate immune mechanismsinsightmouse modelpathogenpathogenic bacteriapressurepreventreverse geneticstraffickingtransmission processviral transmission
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The innate immune response is a critical component of host defense against infection. Alpha-defensins, one
family of antimicrobial peptides, are an evolutionarily conserved class of innate immune effectors with well-
described anti-bacterial activity; however, their role in viral immunity is less well understood. The potent
neutralization of diverse viruses by alpha-defensins has been described in vitro and in cell culture. By focusing
on human adenovirus and papillomavirus, we have identified a common mechanism whereby alpha-defensins
bind to the viral capsid and alter uncoating during cell entry to block infection. Recently, we have found that
viruses transmitted by the oral/fecal route (e.g., rotavirus and enteric adenovirus) are selectively resistant to
the antiviral activity of alpha-defensins from their host species while remaining sensitive to non-host alpha-
defensins. In some cases, the host alpha-defensins even increase or enhance the infection of these viruses,
leading us to hypothesize that enteric viruses have evolved to either evade or hijack these host defense
peptides to increase infection and transmission. To test this hypothesis, we will study the enhancement and
neutralization of rotavirus by host and non-host alpha-defensins. Rotaviruses are important human pathogens
and a deeper understanding of host factors that dictate their tropism is important for understanding
transmission. These studies will combine biochemical and genetic approaches to identify alpha-defensin
binding determinants on the viral capsids and to identify alpha-defensin properties that differentiate neutralizing
and enhancing activities. We will also identify the mechanisms of rotavirus neutralization and enhancement.
Finally, we will determine whether or not these mechanisms alter viral infection in vivo.
To determine whether the antiviral mechanism that we have uncovered in our studies of adenovirus and HPV
is general, we will also dissect the mechanism of parvovirus inhibition. Parvoviruses, particularly adeno-
associated virus, are important viral vectors. In addition, there are well known (e.g., B19) and emerging (e.g.,
bocavirus) parvoviruses that are important human pathogens. These studies will be facilitated by high
resolution structural studies of clinically relevant viral vectors. From these comparative studies of two
disparate families of non-enveloped viruses in combination with our prior insights from human adenovirus and
papillomavirus, we will gain a deeper understanding of the function of a critical component of the immune
system that may be a common factor in the pathogenesis of many viruses. These studies may also aid in the
development of alpha-defensins as therapeutics and inform vaccine design.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.ppat.1004360
发表时间:
2014-09
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Tenge VR, Gounder AP, Wiens ME, Lu W, Smith JG]
通讯作者:
Smith JG
Directed Evolution of Adenoviruses.
腺病毒的定向进化。
DOI:
10.1007/978-1-4939-3271-9_13
发表时间:
2016
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Smith,JasonG]
通讯作者:
Smith,JasonG
DOI:
10.1371/journal.ppat.1004186
发表时间:
2014-07
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Wiens ME, Wilson SS, Lucero CM, Smith JG]
通讯作者:
Smith JG
α-Defensin HD5 Inhibits Human Papillomavirus 16 Infection via Capsid Stabilization and Redirection to the Lysosome.
α-防御素HD5通过衣壳稳定和重定向抑制人乳头瘤病毒16感染。
DOI:
10.1128/mbio.02304-16
发表时间:
2017-01-24
期刊:
mBio
影响因子:
6.4
作者:
[Wiens ME, Smith JG]
通讯作者:
Smith JG
DOI:
10.3390/v10050225
发表时间:
2018-04-26
期刊:
Viruses
影响因子:
--
作者:
[Holly MK, Smith JG]
通讯作者:
Smith JG
Anti-viral Mechanisms of Defensins
-
批准号:10398866
-
项目类别:
-
资助金额:$65.02万
-
财政年份:2014
-
负责人:ROBERT MCKENNA
-
依托单位:
STRUCTURAL STUDIES OF PROTEINS ASSOCIATED WITH HUMAN DISEASES
-
批准号:8363521
-
项目类别:
-
资助金额:$5.36万
-
财政年份:2011
-
负责人:ROBERT MCKENNA
-
依托单位:
STRUCTURAL STUDIES OF PROTEINS ASSOCIATED WITH HUMAN DISEASES
-
批准号:8171501
-
项目类别:
-
资助金额:$9.52万
-
财政年份:2010
-
负责人:ROBERT MCKENNA
-
依托单位:
STRUCTURAL STUDIES OF PROTEINS ASSOCIATED WITH HUMAN DISEASES
-
批准号:7955564
-
项目类别:
-
资助金额:$5.76万
-
财政年份:2009
-
负责人:ROBERT MCKENNA
-
依托单位:
STRUCTURAL STUDIES OF PROTEINS ASSOCIATED WITH HUMAN DISEASES
-
批准号:7721330
-
项目类别:
-
资助金额:$1.44万
-
财政年份:2008
-
负责人:ROBERT MCKENNA
-
依托单位:
AAV capsids and their cellular interactions
-
批准号:10061606
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2007
-
负责人:ROBERT MCKENNA
-
依托单位:
AAV capsids and their cellular interactions
-
批准号:10296666
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2007
-
负责人:ROBERT MCKENNA
-
依托单位:
AAV capsids and their cellular interactions
-
批准号:10538552
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2007
-
负责人:ROBERT MCKENNA
-
依托单位:
INTEGRATING HIV & OTHER PREVENTION SERVICES INTO REPRODUCTIVE HEALTH
-
批准号:7401695
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2004
-
负责人:ROBERT MCKENNA
-
依托单位:
INTEGRATING HIV & OTHER PREVENTION SERVICES INTO REPRODUCTIVE HEALTH
-
批准号:7490012
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2004
-
负责人:ROBERT MCKENNA
-
依托单位:
INTEGRATING HIV & OTHER PREVENTION SERVICES INTO REPRODUCTIVE HEALTH
-
批准号:7416989
-
项目类别:
-
资助金额:$25.18万
-
财政年份:2004
-
负责人:ROBERT MCKENNA
-
依托单位:
INTEGRATING HIV & OTHER PREVENTION SERVICES INTO REPRODUCTIVE HEALTH
-
批准号:7401693
-
项目类别:
-
资助金额:$30.24万
-
财政年份:2004
-
负责人:ROBERT MCKENNA
-
依托单位:
INTEGRATING HIV & OTHER PREVENTION SERVICES INTO REPRODUCTIVE HEALTH
-
批准号:7401694
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2004
-
负责人:ROBERT MCKENNA
-
依托单位:
NATIONAL EMPHYSEMA TREATMENT TRIAL (NETT)
-
批准号:6416285
-
项目类别:
-
资助金额:$23.8万
-
财政年份:2000
-
负责人:ROBERT MCKENNA
-
依托单位:
NATIONAL EMPHYSEMA TREATMENT TRIAL (NETT)
-
批准号:6306572
-
项目类别:
-
资助金额:$0.1万
-
财政年份:1999
-
负责人:ROBERT MCKENNA
-
依托单位:
NATIONAL EMPHYSEMA TREATMENT TRIAL (NETT)
-
批准号:6264867
-
项目类别:
-
资助金额:$0.1万
-
财政年份:1998
-
负责人:ROBERT MCKENNA
-
依托单位:
海外基金